Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle
Open Access

Steroidal Antagonists of Progesterone- and Prostaglandin E1-Induced Activation of the Cation Channel of Sperm

Erick J. Carlson, Gunda I. Georg and Jon E. Hawkinson
Molecular Pharmacology January 2022, 101 (1) 56-67; DOI: https://doi.org/10.1124/molpharm.121.000349
Erick J. Carlson
Department of Medicinal Chemistry (E.J.C., G.I.G., J.E.H.) and Institute for Therapeutics Discovery and Development (G.I.G., J.E.H.), University of Minnesota, Minneapolis, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gunda I. Georg
Department of Medicinal Chemistry (E.J.C., G.I.G., J.E.H.) and Institute for Therapeutics Discovery and Development (G.I.G., J.E.H.), University of Minnesota, Minneapolis, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jon E. Hawkinson
Department of Medicinal Chemistry (E.J.C., G.I.G., J.E.H.) and Institute for Therapeutics Discovery and Development (G.I.G., J.E.H.), University of Minnesota, Minneapolis, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Structures of CatSper activators PROG, PGE1, and l-sirenin.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Structures of CatSper antagonists MPA, LNG, and ALDO.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Structures of T-type calcium channel blockers mibefradil, NNC55-0396, and ML218.

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    The T-type CCBs mibefradil and ML218 inhibit PROG-, PGE1-, l-sirenin-, and potassium-induced calcium influx in human sperm. (A) Representative FLIPR traces showing concentration-dependent reduction of PROG-mediated increase in [Ca2+]i by mibefradil (upper) and ML218 (lower). (B–E) Potencies of mibefradil and ML218 for inhibiting (B) PROG-, (C) PGE1-, (D) l-sirenin-, or (E) high K+/high pH-induced calcium influx. Ligand-induced activation used EC80 concentrations of activator (30 nM PROG, 10 nM PGE1, 3 µM l-sirenin). Buffer containing 140 mM K+, pH 8.2 was added to elicit alkalinization/depolarization calcium influx (E). The data in B–E are plotted as the mean ±SEM and expressed as a percent of the response produced by each activator alone. IC50 and n values are in Table 1.

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    PROG analogs have a broad range of potencies for eliciting calcium influx in human sperm. (A) Representative FLIPR traces showing the concentration-dependent increase in calcium influx produced by PROG. (B) Concentration-response curves comparing potencies of parent compound PROG and C17- and/or C6-modified analogs: 1, PROG; 4, MPA; 20, 6α-methylprogesterone; 25, 17α-hydroxyprogesterone; 29, 17α-acetoxyprogesterone; 30, 17α-hydroxy-6α-methylprogesterone. Data are plotted as mean ±SEM and expressed as a percent of the response produced by a saturating concentration of PROG (3 µM). EC50, Emax, and n values are in Tables 2 and 3.

  • Fig. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    Several clinically used progestins, antiprogestins, and androgens elicit calcium influx in human sperm. Concentration-response curves for 31, drospirenone; 32, ulipristal; 33, mifepristone; 41, 7β,11β-dimethylandrolone. Data are plotted as mean ±SEM and expressed as a percent of the response produced by a saturating concentration of PROG (3 µM). EC50, Emax, and n values are in Table 3.

  • Fig. 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 7.

    The steroids MPA, LNG, and ALDO inhibit PROG-, PGE1-, and l-sirenin-induced calcium influx in human sperm. (A) Representative FLIPR traces showing concentration-dependent reduction of PROG-mediated increase in [Ca2+]i by MPA (upper) and LNG (lower). FLIPR traces for inhibition of PGE1- and l-sirenin-induced calcium influx by MPA and LNG are in Supplemental Figs. 7 and 8, respectively, and traces for ALDO antagonism of all three activators are in Supplemental Fig. 9. (B–E) Potencies of MPA, LNG, or ALDO for inhibiting (B) PROG-, (C) PGE1-, (D) l-sirenin-, or (E) high K+/high pH-induced calcium influx. Ligand-induced activation used EC80 concentrations of activator (30 nM PROG, 10 nM PGE1, 3 µM l-sirenin). Buffer containing 140 mM K+, pH 8.2 was added to elicit alkalinization/depolarization calcium influx (E). The data in B–E are plotted as the mean ±SEM and expressed as a percent of the response produced by each activator alone. IC50 and n values are in Table 4.

  • Fig. 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 8.

    T-type CCBs produce an insurmountable block of PROG-induced calcium influx in human sperm. (A) Mibefradil and (B) ML218 reduce the PROG Emax in a concentration-dependent manner with little change in EC50 values, indicating an insurmountable inhibition. Emax, EC50, slopes, and n values are in Table 5. The data are plotted as the mean ±SEM and expressed as a percent of the response produced by a saturating concentration of PROG (3 µM).

  • Fig. 9.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 9.

    MPA, LNG, and ALDO produce a surmountable inhibition of PROG-induced calcium influx in human sperm. Increasing concentrations of (A) MPA, (B) LNG, and (C) ALDO increase the observed EC50 values for PROG with little change in Emax values (left panels). The same data are plotted in the Schild analyses (right panels) indicating surmountable inhibition. Emax, EC50, and n values are in Table 5, and pKB values are in Table 6. The data are plotted as the mean ±SEM and expressed as a percent of the response produced by a saturating concentration of PROG (3 µM).

  • Fig. 10.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 10.

    T-type CCBs inhibit total, progressive, and hyperactivated motility, whereas steroidal CatSper antagonists selectivity inhibit hyperactivated motility in human sperm. A. Total (solid) and progressive (checkered) motility was monitored by CASA in the presence of increasing concentrations of inhibitor. The steroidal antagonists LNG, ALDO, and MPA show little or no effect on total and progressive motility, whereas MBF and ML218 completely block these motility parameters. Asterisks indicate differences from vehicle control. B. HAM was induced with 100 nM PROG under capacitating conditions. The steroidal CatSper antagonist MPA reduced the percentage of sperm cells displaying HAM to the level of the vehicle control, whereas LNG and ALDO were less potent. The T-type CCBs MBF and ML218 reduced the percentage of sperm cells displaying HAM to zero. Asterisks indicate differences from the PROG only control. In both A and B, data are presented as mean ±SD and are expressed as a percent of the total sperm cell population analyzed. Statistical significance: * p < 0.05, ** p < 0.005 and **** p < 0.0001.

  • Fig. 11.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 11.

    SAR of CatSper activation by progesterone analogs.

Tables

  • Figures
  • Additional Files
    • View popup
    TABLE 1

    Potencies of mibefradil and ML218 to inhibit calcium influx produced by PROG, PGE1, l-sirenin, and high K+/high pH in human sperm

    OpenerBlockerpIC50n
    PROGmibefradil5.17 ± 0.247
    ML2185.02 ± 0.084
    PGE1mibefradil5.08 ± 0.318
    ML2184.87 ± 0.153
    l-sireninmibefradil5.09 ± 0.345
    ML2184.85 ± 0.173
    high K+/high pHmibefradil4.76 ± 0.098
    ML2184.99 ± 0.167
    • Inhibitors were evaluated in the presence of an EC80 concentration of each activator (30 nM PROG, 10 nM PGE1, 3 µM l-sirenin). Buffer containing 140 mM K+, pH 8.2 was added to elicit alkalinization/depolarization calcium influx. pIC50 values are expressed as the mean ±SD with the number of independent experiments indicated by n.

    • View popup
    TABLE 2

    Potencies for PGE1, l-sirenin, PROG, and PROG analogs to elicit calcium influx in human sperm

    #SteroidSteroid Alone+ 30 µM Mibefradil
    pEC50Emax, %npEC50Emax, %n
    Activator1PROG8.43 ± 0.2111178.22 ± 0.15423
    2PGE18.40 ± 0.2410188.33 ± 0.43225
    3l-sirenin6.02 ± 0.2610235.48 ± 0.23223
    A Ring or A–B Ring Fusion103α,5α-pregnanolone6.56 ± 0.218556.40 ± 0.19293
    113α,5β-pregnanolone6.26 ± 0.2510236.47 ± 0.22333
    123β,5α-pregnanolone7.16 ± 0.119947.08 ± 0.31384
    133β,5β-pregnanolone6.89 ± 0.209247.05 ± 0.23374
    145α-dihydroprogesterone6.99 ± 0.058736.95 ± 0.12343
    155β-dihydroprogesterone6.87 ± 0.179536.67 ± 0.35203
    165α,6α-epoxypregnan-3,20-dionea6.08 ± 0.378335.96 ± 0.19123
    175β,6β-epoxypregnan-3,20-dionea6.38 ± 0.07843—<103
    182,2-dimethylprogesteronea6.31 ± 0.16993—<103
    B Ring196β-methylprogesteronea6.58 ± 0.12903—<103
    206α-methylprogesteronea6.16 ± 0.149636.62 ± 0.20183
    216β-hydroxyprogesterone6.91 ± 0.1011636.72 ± 0.09353
    225α-hydroxy-6β-methylpregnan-3,20-dionea5.30 ± 0.55953—<103
    C Ring2311β-hydroxyprogesterone7.73 ± 0.139057.54 ± 0.55524
    2411α-hydroxyprogesterone6.90 ± 0.0810036.93 ± 0.45324
    D Ring2517α-hydroxyprogesterone7.98 ± 0.3511558.02 ± 0.36673
    263α,5β-THDOC5.80 ± 0.2610035.98 ± 0.39184
    273α,5α-THDOC6.05 ± 0.219666.20 ± 0.26374
    2816α-hydroxyprogesterone6.77 ± 0.1810636.71 ± 0.27473
    2917α-acetoxyprogesterone<5318<5373
    3017α-hydroxy-6α-methylprogesterone6.33 ± 0.10963—<103
    • The potency (EC50 values, mean ±SD) and maximum response (Emax) produced by each compound was determined in the absence and presence of 30 µM mibefradil. Emax is expressed as a percent of the response produced by a saturating concentration of PROG (3 µM). The number of independent experiments indicated by n. Fitted parameters were not calculated for compounds producing Emax < 10%.

    • ↵aSynthesized compound (see Supplemental Schemes 1–3 and Synthetic Procedures for synthesis and characterization).

    • View popup
    TABLE 3

    Potencies for clinically used progestins, antiprogestins, endogenous steroid hormones and androgens to elicit calcium influx in human sperm

    #SteroidSteroid Alone+30 µM Mibefradil
    pEC50Emax, %npEC50Emax, %n
    Progestins and Anti-progestins4MPA<5173—<103
    5LNG<5156—<102
    31drospirenone6.28 ± 0.221155—<104
    32ulipristal5.45 ± 0.221063<5125
    33mifepristone (RU-486)5.33 ± 0.301094—<105
    34ulipristal acetate<5273—<103
    35segesterone acetate<5574—<104
    Endogenous6ALDO—<103—<101
    36testosterone6.66 ± 0.221143<5174
    3717β-estradiol6.53 ± 0.25943<5371
    Androgens3811β-methyl-19-nortestosterone6.37 ± 0.328566.27 ± 0.25153
    397α-methyl-19-nortestosterone6.25 ± 0.378676.29262
    407α,11β-dimethylandrolone6.06 ± 0.49809<5113
    417β,11β-dimethylandrolone5.41 ± 0.24425<5263
    • The potency (EC50 values, mean ±SD) and maximum response (Emax) produced by each compound was determined in the absence and presence of 30 µM mibefradil. Emax is expressed as a percent of the response produced by a saturating concentration of PROG (3 µM). The number of independent experiments indicated by n. Fitted parameters were not calculated for compounds producing Emax < 10%.

    • View popup
    TABLE 4

    Potencies of MPA, LNG, and ALDO to inhibit calcium influx produced by PROG, PGE1, l-sirenin, and high K+/high pH in human sperm

    OpenerAntagonistpIC50n
    PROGMPA5.18 ± 0.3912
    LNG4.49 ± 0.239
    ALDO4.48 ± 0.1610
    PGE1MPA5.01 ± 0.2611
    LNG4.52 ± 0.116
    ALDO4.24 ± 0.2010
    l-SireninMPA5.21 ± 0.337
    LNG4.09 ± 0.055
    ALDO4.21 ± 0.169
    high K+/high pHMPA<54
    LNG<54
    ALDO<54
    • Inhibitors were evaluated in the presence of an EC80 concentration of each activator (30 nM PROG, 10 nM PGE1, 3 µM l-sirenin). Buffer containing 140 mM K+, pH 8.2 was added to elicit alkalinization/depolarization calcium influx. IC50 values are expressed as the mean ±SD with the number of independent experiments indicated by n.

    • View popup
    TABLE 5

    T-type CCBs mibefradil and ML218 reduce the maximal response, whereas MPA, LNG, and ALDO reduce the potency of PROG-, PGE1-, and l-sirenin-induced calcium influx in human sperm

    InhibitorProgesteronePGE1l-Sirenin
    Conc., µMpEC50Emax, %npEC50Emax, %npEC50Emax, %n
    MBF18.71 ± 0.299038.16 ± 0.088735.71 ± 0.01872
    108.14 ± 0.206948.53 ± 0.375345.57 ± 0.41584
    308.31 ± 0.422348.23 ± 0.514135.37 ± 0.51204
    1008.26 ± 0.24163—<105—<103
    ML21818.12 ± 0.138338.20 ± 0.10733ND
    107.77 ± 0.354238.01 ± 0.056435.61 ± 0.45382
    30—<1037.86 ± 0.04153—42
    100—<103—<102—22
    MPA107.69 ± 0.4010637.83 ± 0.4311135.56 ± 0.151083
    307.51 ± 0.389937.34 ± 0.1510535.24 ± 0.58100a3
    1006.64 ± 0.07100a36.96 ± 0.03100a34.71 ± 0.21100a3
    LNG107.58 ± 0.1611087.78 ± 0.309645.16 ± 0.08954
    307.06 ± 0.26100a47.48 ± 0.1810644.83 ± 0.161024
    1006.64 ± 0.06100a47.29 ± 0.2211744.52 ± 0.03100a3
    ALDO107.44 ± 0.1411447.88 ± 0.2210745.28 ± 0.281044
    307.09 ± 0.3610647.82 ± 0.319945.10 ± 0.241094
    1006.59 ± 0.16100a47.44 ± 0.31100a44.51 ± 0.21100a4
    • EC50 values are expressed as the mean ±SD, and Emax values are the percent of a saturating concentration of PROG (3 µM). The number of independent experiments is indicated by n. EC50, Emax, and n values for PROG, PGE1, and l-sirenin in the absence of inhibitor are in Table 2. Fitted parameters were not calculated for conditions producing Emax < 10.

    • ↵a Constrained value due to rightward shift of dose response.

    • View popup
    TABLE 6

    Dissociation constants for steroidal antagonists of activator-induced calcium influx in human sperm

    OpenerAntagonistSchildLeff-Dougall
    pKB
    PROGMPA6.19 ± 1.756.16 ± 0.39
    LNG6.80 ± 0.105.47 ± 0.23
    ALDO5.38 ± 0.275.46 ± 0.16
    PGE1MPA5.38 ± 0.596.00 ± 0.26
    LNG3.36 ± 0.415.50 ± 0.11
    ALDO3.14 ± 0.955.22 ± 0.20
    l-SireninMPA5.22 ± 0.335.20 ± 0.20
    LNG4.25 ± 0.235.07 ± 0.05
    ALDO4.82 ± 1.035.19 ± 0.16
    • The Schild pKB values (mean ± standard error) were obtained using the EC50 values corresponding to the pEC50 values listed in Table 5 derived from 3–8 independent experiments. For all Schild analyses, the slopes of the regression lines had values of 1.0 within the 95% CI. The Leff-Dougall pKB values (mean ± SD) were obtained using the IC50 values corresponding to the pIC50 values listed in Table 4 derived from 5–12 independent experiments.

Additional Files

  • Figures
  • Tables
  • Data Supplement

    • Supplemental Data -

      Supplemental General Synthesis Information

      Supplemental Scheme 1. Synthesis of 2,2-dimethylprogesterone

      Supplemental Scheme 2. Synthesis of 6alpha-methylprogesterone

      Supplemental Scheme 3.  Sythesis of 5alpha, 6alpha- and 5 beta, 6beta-epoxyprogesterone

      Supplemental Figure 1.  Representative FLIPR traces showing inhibition of PGE1-, l-sirenin- and elevated K+ - induced calcium influx by mibefradil

      Supplemental Figure 2.  Representative FLIPR traces showing inhibition of PGE1-, l-sirenin- and elevated K+ - induced calcium influx by MIL218

      Supplemental Figure 3.  FLIPR traces demonstrating that ML218 did not elicit calcium influx in human sperm cells

      Supplemental Figure 4. Chemical structures of compouonds in Table 2

      Supplemental Figure 5. Ketalized steroids have little or no activity in the calcium influx assay in human sperm

      Supplemental Figure 6. Chemical structures of compounds in Table 3

      Supplemental Figure 7. MPA inhibits PGE1- and l-sirenin- induced calcium influx in human sperm.

      Supplemental Figure 8. LNG inhibits PGE1- and l-sirenin- induced calcium influx in human sperm.

      Supplemental Figure 9. ALDO inhibits PROG-, PGE1- and l-sirenin-induced calcium influx in human sperm. 

      Supplemental Figure 10. T-type CCBs produce an insurmountable block, but MPA, LNG, and ALDO produce a surmountable inhibition of PGE1-induced calcium influx in human sperm.

      Supplemental Figure 11. T-type CCBs produce an insurmountable block, but MPA, LNG, and ALDO produce a surmountable inhibition of l-sirenin-induced calcium influx in human sperm.

      Supplemental Figure 12. T-type CCBs and steroid antagonists do not block the calcium influx produced by the calcium ionophore A23187.

      Supplemental Figure 13. T-type CCBs and steroidal  CatSper antagonists inhibit PGE1-induced hyperactivated motility (HAM) in human sperm.

      1H, 13C, DEPT, NOESY NMR spectra









PreviousNext
Back to top

In this issue

Molecular Pharmacology: 101 (1)
Molecular Pharmacology
Vol. 101, Issue 1
1 Jan 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Steroidal Antagonists of Progesterone- and Prostaglandin E1-Induced Activation of the Cation Channel of Sperm
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Steroidal Antagonists of CatSper

Erick J. Carlson, Gunda I. Georg and Jon E. Hawkinson
Molecular Pharmacology January 1, 2022, 101 (1) 56-67; DOI: https://doi.org/10.1124/molpharm.121.000349

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Steroidal Antagonists of CatSper

Erick J. Carlson, Gunda I. Georg and Jon E. Hawkinson
Molecular Pharmacology January 1, 2022, 101 (1) 56-67; DOI: https://doi.org/10.1124/molpharm.121.000349
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Visual Overview
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Fatty acid amide hydrolase in cisplatin nephrotoxicity
  • eCB Signaling System in hiPSC-Derived Neuronal Cultures
  • Benzbromarone relaxes airway smooth muscle via BK activation
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics